Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29145
Title: | Baseline characteristics of patients enrolled in LEMQoL, a study assessing health-related quality of life in RRMS patients treated with alemtuzumab in a real-world clinical setting | Authors: | VAN WIJMEERSCH, Bart Patti, F. Hobart, J. Kizlaitiene, R. Vanderdonckt, P. Shor, S. Andreasen, A. K. Uitdehaag, B. M. |
Issue Date: | 2019 | Publisher: | WILEY | Source: | EUROPEAN JOURNAL OF NEUROLOGY, 26, p. 866-866 | Notes: | [Van Wijmeersch, B.] Hasselt Univ, BIOMED, Rehabil & MS Ctr Overpelt, Hasselt, Belgium. [Patti, F.] Univ Catania, Teaching Hosp Policlin, Multiple Sclerosis Ctr, Catania, Italy. [Hobart, J.] Plymouth Univ, Peninsula Sch Med, Plymouth, Devon, England. [Hobart, J.] Plymouth Univ, Peninsula Sch Dent, Plymouth, Devon, England. [Kizlaitiene, R.] Vilnius Univ, Hosp Santariskiu Clin, Ctr Neurol, Clin Neurol & Neurosurg,Fac Med, Vilnius, Lithuania. [Vanderdonckt, P.] AZ Groeninge, Kortrijk, Belgium. [Shor, S.; Andreasen, A. K.] Sanofi, Amsterdam, Netherlands. [Uitdehaag, B. M.] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands. | Document URI: | http://hdl.handle.net/1942/29145 | ISSN: | 1351-5101 | e-ISSN: | 1468-1331 | ISI #: | 000474481004025 | Category: | M | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Show full item record
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.